BR112014006432B8 - Método in vitro para diagnosticar se um indivíduo tem ou não câncer, método implementado por computador, produto de programa de computador - Google Patents

Método in vitro para diagnosticar se um indivíduo tem ou não câncer, método implementado por computador, produto de programa de computador

Info

Publication number
BR112014006432B8
BR112014006432B8 BR112014006432A BR112014006432A BR112014006432B8 BR 112014006432 B8 BR112014006432 B8 BR 112014006432B8 BR 112014006432 A BR112014006432 A BR 112014006432A BR 112014006432 A BR112014006432 A BR 112014006432A BR 112014006432 B8 BR112014006432 B8 BR 112014006432B8
Authority
BR
Brazil
Prior art keywords
cancer
lung cancer
methods
subjects
subject
Prior art date
Application number
BR112014006432A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112014006432B1 (pt
BR112014006432A2 (pt
Inventor
Riel-Mehan Michael
A E Stewart Alex
M Ostroff Rachel
Alaric Williams Stephen
N Brody Edward
Original Assignee
Somalogic Inc
Somalogic Operating Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc, Somalogic Operating Co Inc filed Critical Somalogic Inc
Publication of BR112014006432A2 publication Critical patent/BR112014006432A2/pt
Publication of BR112014006432B1 publication Critical patent/BR112014006432B1/pt
Publication of BR112014006432B8 publication Critical patent/BR112014006432B8/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
BR112014006432A 2011-10-24 2011-10-24 Método in vitro para diagnosticar se um indivíduo tem ou não câncer, método implementado por computador, produto de programa de computador BR112014006432B8 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/057499 WO2013062515A2 (en) 2011-10-24 2011-10-24 Lung cancer biomarkers and uses thereof

Publications (3)

Publication Number Publication Date
BR112014006432A2 BR112014006432A2 (pt) 2017-04-04
BR112014006432B1 BR112014006432B1 (pt) 2021-04-06
BR112014006432B8 true BR112014006432B8 (pt) 2022-10-25

Family

ID=48168748

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014006432A BR112014006432B8 (pt) 2011-10-24 2011-10-24 Método in vitro para diagnosticar se um indivíduo tem ou não câncer, método implementado por computador, produto de programa de computador

Country Status (15)

Country Link
EP (1) EP2771692B1 (enExample)
JP (1) JP5986638B2 (enExample)
KR (1) KR101921945B1 (enExample)
CN (2) CN103890586B (enExample)
AU (1) AU2011378427B8 (enExample)
BR (1) BR112014006432B8 (enExample)
CA (3) CA3064363C (enExample)
ES (1) ES2674318T3 (enExample)
IL (2) IL231426A (enExample)
IN (1) IN2014CN01787A (enExample)
MX (1) MX355416B (enExample)
NZ (1) NZ621733A (enExample)
SG (1) SG11201400375SA (enExample)
WO (1) WO2013062515A2 (enExample)
ZA (1) ZA201401476B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2801110C (en) 2010-07-09 2021-10-05 Somalogic, Inc. Lung cancer biomarkers and uses thereof
WO2014179959A1 (en) * 2013-05-09 2014-11-13 The Procter & Gamble Company Method and system for assessing health condition
ES2968004T3 (es) 2014-07-30 2024-05-06 Harvard College Construcción de bibliotecas de sondas
CN104263723B (zh) * 2014-09-15 2017-06-06 南京医科大学 一种与原发性肺癌辅助诊断相关的低频高外显性遗传标志物及其应用
WO2016094330A2 (en) * 2014-12-08 2016-06-16 20/20 Genesystems, Inc Methods and machine learning systems for predicting the liklihood or risk of having cancer
JP6857185B2 (ja) * 2015-09-11 2021-04-14 アプタマー サイエンス インコーポレイテッドAptamer Sciences Inc. 非小細胞肺癌診断用タンパク質バイオマーカーパネル及びこれを用いた非小細胞肺癌診断方法
JP6688884B2 (ja) * 2015-11-05 2020-04-28 ビージーアイ シェンチェン 肺腺癌を検出するためのバイオマーカー及びその使用
US10731166B2 (en) * 2016-03-18 2020-08-04 Caris Science, Inc. Oligonucleotide probes and uses thereof
KR101853118B1 (ko) * 2016-09-02 2018-04-30 주식회사 바이오인프라생명과학 피험체의 폐암 진단을 위한 복합 바이오마커군, 이를 이용하는 폐암 진단용 키트, 복합 바이오마커군의 정보를 이용하는 방법 및 이를 수행하는 컴퓨팅 시스템
EP3539036A4 (en) * 2016-11-08 2020-06-17 President and Fellows of Harvard College MATRIX AND DELETE
CN110402394B (zh) * 2017-03-01 2024-04-26 豪夫迈·罗氏有限公司 用于将关于分析物的存在的生物样品进行分类的系统和方法
WO2018218150A1 (en) 2017-05-26 2018-11-29 President And Fellows Of Harvard College Systems and methods for high-throughput image-based screening
CN109116023B (zh) * 2018-06-14 2021-06-04 郑州大学第一附属医院 一种肺癌标志物抗-mmp12自身抗体及其应用
CN109470859A (zh) * 2018-11-04 2019-03-15 华东医院 一种外泌体蛋白作为鉴别肺结节良恶性标志物及其应用
CN113366116A (zh) 2018-12-13 2021-09-07 哈佛学院院长及董事 用于merfish和其他应用的扩增方法和系统
EP3671210A1 (en) * 2018-12-21 2020-06-24 Biosystems International KFT Lung cancer protein epitomic biomarkers
EP3924974A4 (en) * 2019-02-15 2022-11-16 Biodesix, Inc. PREDICTIVE TEST FOR THE IDENTIFICATION OF PATIENTS WITH EARLY STAGE NSCLC AND AT HIGH RISK OF RECIDENCE AFTER SURGICAL PROCEDURE
CN110473167B (zh) * 2019-07-09 2022-06-17 哈尔滨工程大学 一种基于深度学习的尿沉渣图像识别系统及方法
CN112892619B (zh) * 2019-12-04 2022-07-15 香港城市大学深圳研究院 弧形边缘截面的pdms母模、微流控阀和芯片及其制备
CN116670497A (zh) * 2020-11-11 2023-08-29 乔治·梅森研究基金会股份有限公司 激光捕获显微切割可视化化学物质
KR102613772B1 (ko) * 2021-02-02 2023-12-14 제노마인(주) 폐암 혈액 바이오마커의 검출 방법 및 키트
WO2025144995A1 (en) * 2023-12-29 2025-07-03 Novelna Inc. Lung cancer detection proteins and methods of use thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3316600A (en) * 1999-02-22 2000-09-21 Torben F. Orntoft Gene expression in bladder tumors
US6596503B1 (en) 2000-08-18 2003-07-22 East Carolina University Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
ATE483979T1 (de) * 2004-08-10 2010-10-15 Oncotherapy Science Inc Gen anln in verbindung mit nicht-kleinzelligem lungenkrebs und seine wechselwirkungen mit rhoa
EP2295570A1 (en) * 2005-07-27 2011-03-16 Oncotherapy Science, Inc. Method of diagnosing small cell lung cancer
WO2007015947A2 (en) * 2005-07-29 2007-02-08 Bayer Healthcare Llc Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies
US8445198B2 (en) * 2005-12-01 2013-05-21 Medical Prognosis Institute Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
US8014957B2 (en) * 2005-12-15 2011-09-06 Fred Hutchinson Cancer Research Center Genes associated with progression and response in chronic myeloid leukemia and uses thereof
EP2090665A2 (en) * 2006-10-20 2009-08-19 Exiqon A/S Novel human microRNAs associated with cancer
GB0803192D0 (en) * 2008-02-22 2008-04-02 Mubio Products Bv SCLC biomarker panel
US10359425B2 (en) * 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
SI2340506T1 (sl) * 2008-09-09 2016-02-29 Somalogic, Inc. Biomarkerji za pljučni rak in njihove uporabe
US8541170B2 (en) 2008-11-17 2013-09-24 Veracyte, Inc. Methods and compositions of molecular profiling for disease diagnostics
CN102308212A (zh) 2008-12-04 2012-01-04 加利福尼亚大学董事会 用于确定前列腺癌诊断和预后的材料和方法
WO2011100472A1 (en) * 2010-02-10 2011-08-18 The Regents Of The University Of California Salivary transcriptomic and proteomic biomarkers for breast cancer detection
KR20130056855A (ko) 2010-03-01 2013-05-30 카리스 라이프 사이언스 룩셈부르크 홀딩스 치료진단용 생물학적 지표들
KR20130043104A (ko) 2010-04-06 2013-04-29 카리스 라이프 사이언스 룩셈부르크 홀딩스 질병용 순환 생물학적 지표들

Also Published As

Publication number Publication date
AU2011378427B8 (en) 2015-08-27
EP2771692A4 (en) 2015-08-26
KR20140082840A (ko) 2014-07-02
CN106168624A (zh) 2016-11-30
IL252163A0 (en) 2017-07-31
MX355416B (es) 2018-04-18
CA2847188C (en) 2020-02-18
CA3064363C (en) 2022-05-17
CN103890586B (zh) 2016-06-29
BR112014006432B1 (pt) 2021-04-06
IL231426A0 (en) 2014-04-30
MX2014004860A (es) 2014-05-27
AU2011378427A1 (en) 2013-05-16
CA3006793C (en) 2020-02-18
WO2013062515A3 (en) 2014-04-17
IN2014CN01787A (enExample) 2015-05-29
SG11201400375SA (en) 2014-04-28
EP2771692A2 (en) 2014-09-03
CA3064363A1 (en) 2013-05-02
JP2015501154A (ja) 2015-01-15
BR112014006432A2 (pt) 2017-04-04
AU2011378427A8 (en) 2015-08-27
ZA201401476B (en) 2016-06-29
CA2847188A1 (en) 2013-05-02
ES2674318T3 (es) 2018-06-28
WO2013062515A2 (en) 2013-05-02
CA3006793A1 (en) 2013-05-02
CN103890586A (zh) 2014-06-25
IL231426A (en) 2017-06-29
EP2771692B1 (en) 2018-04-18
JP5986638B2 (ja) 2016-09-06
NZ621733A (en) 2015-05-29
KR101921945B1 (ko) 2018-11-26
AU2011378427B2 (en) 2015-07-16
CN106168624B (zh) 2018-03-13

Similar Documents

Publication Publication Date Title
BR112014006432B8 (pt) Método in vitro para diagnosticar se um indivíduo tem ou não câncer, método implementado por computador, produto de programa de computador
BR112013003391B8 (pt) Método para diagnosticar câncer pancreático em um indivíduo
BR112012032537A2 (pt) biomarcadores de câncer de pulmão e suas utilizações
BR112014007214A8 (pt) Método para determinar a probabilidade de que um indivíduo tenha risco elevado de um evento cardiovascular, método para avaliação do risco de um evento cardiovascular futuro e método implementado por computador para avaliação do risco de um evento cardiovascular
GB2478441A (en) Lung cancer biomarkers and uses thereof
Sanchez et al. Factors influencing the prevalence of Salmonella spp. in swine farms: a meta-analysis approach
BR112014015603B1 (pt) métodos para sondagem de múltiplos alvos em uma amostra biológica e para análise da amostra biológica de multiplexação de alta produtividade.
HK1205764A1 (en) Tuberculosis biomarkers and uses thereof
BR112018073178A2 (pt) método, matriz e uso dos mesmos
MX373696B (es) Dispositivos, metodos y equipos de prueba para el analisis electronico de analitos.
BR112014011818A2 (pt) método para realizar ensaios de quantificação
WO2019055661A8 (en) Preeclampsia biomarkers and related systems and methods
MX369610B (es) Metodos, dispositivos y sistemas para analisis de muestras.
Lippi et al. Academy of Emergency Medicine and Care-Society of Clinical Biochemistry and Clinical Molecular Biology consensus recommendations for clinical use of sepsis biomarkers in the emergency department.
Ji et al. Pleural fluid prealbumin and C-reactive protein in the differential diagnosis of infectious and malignant pleural effusions
Song et al. The diagnostic accuracy of liquid exosomes for lung cancer detection: a meta-analysis
BR112015025255A2 (pt) métodos e arranjos para uso no mesmo
Zhang et al. Combined detection of SHOX2 and PTGER4 methylation with serum marker CYFRA21-1 for improved diagnosis of malignant pleural mesothelioma
Liu et al. Low reporting quality of the meta-analyses in diagnostic pathology
Lin et al. Comparison of breast cancer tumor marker test results: A retrospective analysis of paired CA 15-3 and CA 27.29 testing at a national reference laboratory
US9903878B2 (en) Biomarker for human prostate cancer
Saydam Comparison of CD38, ZAP70 and hTERT expression with known prognostic markers in patients with chronic lymphocytic leukemia during five-year follow-up period
Briones Accuracy of the radiometric Bactec in the diagnosis of tuberculous pleural effusion compared to pleural biopsy and clinical course
Zhang Plasma miR-200b-3p level for oral squamous cell carcinoma diagnosis
Sporek Evaluation of the diagnostic and prognostic accuracy of angiopoietin-2 (Ang-2) and neutrophil gelatinase-associated lipocalin (NGAL) as markers of the severity and complications of acute pancreatitis in the early phase of the disease

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/10/2011, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved

Owner name: SOMALOGIC OPERATING CO., INC. (US)